Oncolix, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c0d800b2-1bff-4c1e-ace7-ef227a225641/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-3.4M | 2017-01-01 – 2017-12-31 | evidence 0001477932-18-001291 |
| FY 2016 | $-1.4M | 2016-01-01 – 2016-12-31 | evidence 0001477932-18-001291 |
| FY 2015 | $-78.2k | 2015-01-01 – 2015-12-31 | evidence 0001617819-16-000136 |
| FY 2014 | $-258.0k | 2014-01-01 – 2014-12-31 | evidence 0001617819-15-000004 |
| FY 2013 | $-224.5k | 2013-01-01 – 2013-12-31 | evidence 0001617819-15-000004 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).